Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations
暂无分享,去创建一个
E. Antonarakis | C. Higano | O. Sartor | P. Grivas | N. De Sarkar | Heather H. Cheng | M. Schweizer | E. Yu | C. Paller | D. Olmos | P. Nelson | B. Montgomery | R. Gulati | E. Castro | Elisa M Ledet | C. H. Marshall | Alexandra O. Sokolova | T. Yezefski | R. Lozano | Vadim Sokolov | Heather H. Cheng